Report Categories
View AllRecent Articles
View All
Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain
Expion360 Q2 2025 Earnings EPS Surpasses Estimates as Narrower Loss Signals Cost Discipline
BNL Q1 2026 Earnings Strong EPS Surprise on Adjusted Earnings Revenue Not Disclosed
OCC Q1 2026 Earnings Net Loss of 005 Per Share Reported Stock Gains 788
Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances
FG Merger II Corp FGMC Holds Near 1033 as SPAC Awaits Merger Catalyst
ProMIS Neurosciences PMN Slips 565 as Shares Test Key Support Level
BGSF Edges Lower Amid Modest Pullback Key Support Level Holds
PureCycle Technologies Warrant PCTTW Slips 675 Support Test in Focus